Analysis weighs benefits, risks of Actos
477879
The widely used diabetes pill Actos appears to lower a patient's chances of death, heart attack or stroke, unlike its beleaguered chief rival Avandia, a new analysis shows. However, it also carries an increased risk of nonfatal heart failure, the analysis showed, confirming earlier studies.
609309
The New England Journal of Medicine addresses the controversy about the potential for deadly clots.
225087
NEW YORK - Since Merck&#39;s Vioxx was pulled from the market for increasing the risk of heart attack and stroke in a long-term study, there has been heated debate over whether other, similar medicines, such as Pfizer&#39;s Celebrex and Bextra, carry similar risks
326965
AUSTRALIAâS drug regulator is fast-tracking a review into a class of arthritis drugs which are believed to increase the risk of heart attack.
572058
A new study may help older people and their doctors decide how to treat a very common and dangerous problem Â a bulging abdominal artery threatening to burst.
104752
They're the latest fad in medicine, but a new study shows that they may slightly increase the risk of developing potentially fatal clots
333434
The diabetes drug Actos cuts the risk of heart attack, stroke and death but raises the risk of heart failure, according to one study published on Tuesday, while a second confirmed disputed findings that rival Avandia raises heart risks.
315794
While researchers plan to look at the use of all NSAIDs in clinical trials, people shouldn&#39;t take high doses or for too long. By Amanda Gardner.
411659
Millions of people who take Celebrex to treat arthritis have been left with a difficult decision to make after a study showed Celebrex increases the risk of heart attacks and strokes when taken in large doses.
233235
NEW YORK  - Insulin, Glucotrol, and drugs like Avandia and Actos are all effective treatments for diabetes, but they can produce weight gain.
583563
a widely prescribed arthritis treatment - more than doubled patients&#39; risk of heart problems in a clinical study. The announcement, 11 weeks after Merck &amp; Co.
761481
Provenge supporters weigh in on an FDA decision.
143733
The move follows recent studies suggesting that the medications might cause heart attacks.
356356
Older men with early-stage prostate cancer are not taking a big risk if they keep an eye on the disease instead of treating it right away, suggests the largest study to look at this issue since PSA tests became popular
247430
Two new studies are offering mixed signals about the long-term safety of repeatedly giving pregnant women steroid drugs intended to prevent complications once a premature delivery seems likely.
476762
GAITHERSBURG, Md. -- Federal advisers yesterday said that drug-coated stents, which have been implanted in millions, offer clear benefits to many patients but present higher clotting risks to others, suggesting they may be overused.
87010
New data are due out on a promising cholesterol drug. But there are doubters.